Chromosomal translocation products engender new intracellular therapeutic technologies.
Chromosomal translocations occur in leukemias, lymphomas, sarcomas and some epithelial tumors and some generate unique fusion proteins. These translocation products may provide tumor-specific targets for the development of new therapeutic strategies tailored to a malignant cell.
Главные авторы: | Rabbitts, T, Stocks, MR |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2003
|
Схожие документы
-
Chromosomal translocation master genes, mouse models and experimental therapeutics.
по: Rabbitts, T
Опубликовано: (2001) -
Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
по: Pérez-Martínez, D, и др.
Опубликовано: (2010) -
Mouse models of human chromosomal translocations and approaches to cancer therapy.
по: Rabbitts, T, и др.
Опубликовано: (2001) -
The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism.
по: Collins, E, и др.
Опубликовано: (2002) -
LMO2 at 25 years: a paradigm of chromosomal translocation proteins
по: Jennifer Chambers, и др.
Опубликовано: (2015-01-01)